Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · IEX Real-Time Price · USD
0.560
-0.011 (-1.86%)
At close: Jul 19, 2024, 12:00 AM
0.580
+0.020 (3.53%)
Pre-market: Jul 22, 2024, 9:16 AM EDT
TNXP Employees
Tonix Pharmaceuticals Holding had 103 employees as of December 31, 2023. The number of employees decreased by 14 or -11.97% compared to the previous year.
Employees
103
Change (1Y)
-14
Growth (1Y)
-11.97%
Revenue / Employee
$99,515
Profits / Employee
-$957,204
Market Cap
9.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
PAVmed | 107 |
Pieris Pharmaceuticals | 50 |
Plus Therapeutics | 20 |
ABVC BioPharma | 19 |
Moleculin Biotech | 18 |
Elevai Labs | 18 |
Coeptis Therapeutics | 7 |
MIRA Pharmaceuticals | 3 |
TNXP News
- 5 days ago - Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025 - Accesswire
- 11 days ago - Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering - GlobeNewsWire
- 13 days ago - Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering - GlobeNewsWire
- 13 days ago - Tonix Pharmaceuticals Announces Proposed Public Offering - GlobeNewsWire
- 14 days ago - Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia - GlobeNewsWire
- 21 days ago - Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program - GlobeNewsWire
- 25 days ago - Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 27 days ago - Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024 - GlobeNewsWire